Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Looks like the recertification of the 336

TPL policy. It looks to me that it has passed the reexam request up to Jan. 30-2007. Currently, I believe, there have been two additional request made. One by Fish and Richardson, and one by White and Case. Who are apparently working for the plaintiffs in our current litigation.

It seems to me that since the KSR ruling the current trend is to site different combinations of prior art to make their challenges.

Share
New Message
Please login to post a reply